ELISA/assay

Human Complement Component 9, C9 ELISA Kit

MBS700165

48-Strip-Wells

565 USD

ELISA Kit

Human Complement Component 9, C9 ELISA Kit

complement component 9

Human Complement Component 9; C9 ELISA Kit; complement component 9

complement component C9; Complement component C9; complement component C9; complement component 9

C9

C9; C9; C9D; ARMD15

CO9_HUMAN

Human

559

This assay has high sensitivity and excellent specificity for detection of Human C9. No significant cross-reactivity or interference between Human C9 and analogues was observed.

Unopened test kits should be stored at 2 to 8 degree C upon receipt. Please refer to pdf manual for further storage instructions.

Samples: Serum, plasma, urine. Detection Range: 10.97 pg/ml-8000 pg/ml. Sensitivity: 10.97 pg/ml

Intra-assay Precision: Intra-assay Precision (Precision within an assay): CV% is less than 8%. Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV% is less than 10%. Three samples of known concentration were tested in twenty assays to assess. Detection Wavelength: 450 nm. Sample Volume: 50-100ul. Protein Biological Process 1: Complement. Protein Biological Process 3: Complement alternate pathway

Principle of the Assay: The microtiter plate provided in this kit has been pre-coated with an antibody specific to C9. Standards or samples are then added to the appropriate microtiter plate wells with a HRP-conjugated antibody preparation specific for C9 to each microplate well and incubated. Then a TMB (3,3',5,5' tetramethyl-benzidine) substrate solution is added to each well. Only those wells that contain C9, HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm +/- 2 nm. The concentration of C9 in the samples is then determined by comparing the O.D. of the samples to the standard curve.

4502511

NP_001728.1

NM_001737.3

P02748

63,173 Da

Amoebiasis Pathway (167324); Amoebiasis Pathway (167191); Complement Activation, Classical Pathway (198823); Complement And Coagulation Cascades Pathway (198880); Complement And Coagulation Cascades Pathway (83073); Complement And Coagulation Cascades Pathway (484); Complement Cascade Pathway (106405); Immune System Pathway (106386); Innate Immune System Pathway (106387); Prion Diseases Pathway (101144)

This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]

Function: Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC.

48-Strip-Wells

565 USD

96-Strip-Wells

810

5x96-Strip-Wells

2750

10x96-Strip-Wells

5150